Sanara MedTech Inc. — Director's Dealing 2023

Apr 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2023-04-12

Reporting Person: McNeil Michael D. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-12	Common Stock	M	1000	$6.00	Acquired	23025	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-12	Employee Stock Option (right to buy)	$6.00	M	1000	Disposed	2023-04-13	Common Stock (1000)	Direct

Footnotes

F1: Pursuant to the terms of the option award agreement, the option vested in full on March 15, 2019 in connection with the closing of the Share Exchange Agreement between the issuer and CGI Cellerate RX, LLC, which was deemed to be a change of control of the issuer.